ArticleThe Journal of urology2024

Cardiovascular Risk in Prostate Cancer Patients Using Luteinizing Hormone-Releasing Hormone Agonists or a Gonadotropin-Releasing Hormone Antagonist.

E David Crawford et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.